Skip to main content

New companies to commercialise neuroscience discoveries

Neurogenomics has significant commercial potential by way of gene targets for enhancement of brain function and treatment of brain-based disease.

Written byJohn Borchardt
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00

More than half the genes of the human genome have roles in the unique functions performed by the brain and central nervous system. With the Human Genome Project nominally complete and companion projects close to providing the encyclopaedia of genes for other mammals, the race now begins to determine the function of genes involved in brain function and develop strategies for using this knowledge to treat neurological diseases. Neurogenomics is the new field of elucidating genomic function in the brain.

"The neurosciences have remained a leading growth area of biomedical research for more than 30 years, attracting scientists to the greatest challenge in biology, the understanding of the functions, capacities and diseases of the brain," according to Warren G. Young director of neuropharmacology computing at The Scripps Research Institute in La Jolla, California. His Scripps colleague Floyd E. Bloom, chairman of the department of neuropharmacology agrees noting, "Neuroscience offers the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Related articles background image
The Scientist Digest cover September 2026
September 2026

Multiplex Microscopy Becomes Easier with Encoded Antibodies

A new system that enables researchers to uniquely tag monoclonal antibodies for use in microscopy could help simplify complex imaging studies.

View this Issue
Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Alamar Biosciences logo
Engineering CAR-Neutrophils In Vivo to Target Glioblastoma

Engineering CAR-Neutrophils In Vivo to Target Glioblastoma

Miltenyi
Best Practices for qPCR Assay Design and Optimization

Best Practices for qPCR Assay Design and Optimization

Bio-Rad
Beyond the Basics: Strategies for Single-Cell and Spatial Transcriptomics Analysis

Beyond the Basics: Strategies for Single-Cell and Spatial Transcriptomics Analysis

bioxcell

Products

Closeup image of a multi channel pipette dispensing pink liquid into a 96-well plate.

The ASSIST PLUS pipetting robot for affordable workflow automation

Integra Logo
Single cells in suspension

Rapidly isolate primary cells and make uniform single-cell suspensions with Corning® Cell Strainers

Corning logo
Abstract image representing cell membranes linked together.

CellBrite® Steady Membrane Stain: Cell surface staining built for real-time imaging

Biotium
sino biological logo

Monod Bio Licenses AI-designed Protein Technologies to SignalChem Biotech for Custom Discovery Assays